 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
Enrollment closed: Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis (clinicaltrials.gov) - Jun 14, 2022
P1, N=20, Active, not recruiting, Sponsor: SATO Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting
- | luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
Trial completion date, Trial primary completion date: Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis (clinicaltrials.gov) - Mar 20, 2022
P1, N=20, Recruiting, Sponsor: SATO Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting Trial completion date: Feb 2022 --> Feb 2023 | Trial primary completion date: Dec 2021 --> Dec 2022
- || luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
New P1 trial: Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis (clinicaltrials.gov) - Nov 7, 2021
P1, N=20, Recruiting, Sponsor: SATO Pharmaceutical Co., Ltd.
- |||| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
Trial completion: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis (clinicaltrials.gov) - Oct 11, 2014
P2b, N=334, Completed, Sponsor: Topica Pharmaceuticals
Trial completion date: Feb 2022 --> Feb 2023 | Trial primary completion date: Dec 2021 --> Dec 2022 Active, not recruiting --> Completed
- ||| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
Enrollment closed: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis (clinicaltrials.gov) - May 9, 2013
P2b, N=300, Active, not recruiting, Sponsor: Topica Pharmaceuticals
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
Enrollment change: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis (clinicaltrials.gov) - Oct 27, 2011
P2b, N=300, Active, not recruiting, Sponsor: Topica Pharmaceuticals
Recruiting --> Active, not recruiting N=240 --> 300
- |||||| luliconazole 10% solution (SKX-16) / Sato Pharma, Bausch Health
New P2b trial: Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis (clinicaltrials.gov) - Sep 8, 2011
P2b, N=300, Active, not recruiting, Sponsor: Topica Pharmaceuticals